Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing

SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 27, 2023 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming …